Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs BIOCON - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB BIOCON DR. REDDYS LAB/
BIOCON
 
P/E (TTM) x 19.7 19.7 100.1% View Chart
P/BV x 4.4 1.8 246.2% View Chart
Dividend Yield % 0.6 0.6 114.4%  

Financials

 DR. REDDYS LAB   BIOCON
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-23
BIOCON
Mar-23
DR. REDDYS LAB/
BIOCON
5-Yr Chart
Click to enlarge
High Rs4,656388 1,200.6%   
Low Rs3,788192 1,976.8%   
Sales per share (Unadj.) Rs1,481.493.1 1,591.7%  
Earnings per share (Unadj.) Rs270.75.4 5,053.7%  
Cash flow per share (Unadj.) Rs345.714.6 2,363.7%  
Dividends per share (Unadj.) Rs40.001.50 2,666.7%  
Avg Dividend yield %0.90.5 183.0%  
Book value per share (Unadj.) Rs1,389.6146.5 948.3%  
Shares outstanding (eoy) m166.531,200.60 13.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.83.1 91.6%   
Avg P/E ratio x15.654.1 28.8%  
P/CF ratio (eoy) x12.219.8 61.7%  
Price / Book Value ratio x3.02.0 153.7%  
Dividend payout %14.828.0 52.8%   
Avg Mkt Cap Rs m703,039347,814 202.1%   
No. of employees `000NANA-   
Total wages/salary Rs m46,46621,810 213.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m246,697111,742 220.8%  
Other income Rs m10,5557,681 137.4%   
Total revenues Rs m257,252119,423 215.4%   
Gross profit Rs m63,86016,611 384.4%  
Depreciation Rs m12,50211,131 112.3%   
Interest Rs m1,4284,190 34.1%   
Profit before tax Rs m60,4858,971 674.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m15,4122,541 606.5%   
Profit after tax Rs m45,0736,430 701.0%  
Gross profit margin %25.914.9 174.1%  
Effective tax rate %25.528.3 90.0%   
Net profit margin %18.35.8 317.5%  
BALANCE SHEET DATA
Current assets Rs m203,161123,340 164.7%   
Current liabilities Rs m85,72185,107 100.7%   
Net working cap to sales %47.634.2 139.1%  
Current ratio x2.41.4 163.5%  
Inventory Days Days79129 61.4%  
Debtors Days Days107117 91.9%  
Net fixed assets Rs m112,638394,078 28.6%   
Share capital Rs m8336,003 13.9%   
"Free" reserves Rs m230,571169,926 135.7%   
Net worth Rs m231,404175,929 131.5%   
Long term debt Rs m1,278152,905 0.8%   
Total assets Rs m315,799517,418 61.0%  
Interest coverage x43.43.1 1,380.3%   
Debt to equity ratio x00.9 0.6%  
Sales to assets ratio x0.80.2 361.7%   
Return on assets %14.72.1 717.4%  
Return on equity %19.53.7 532.9%  
Return on capital %26.64.0 664.8%  
Exports to sales %52.23.1 1,682.8%   
Imports to sales %16.86.0 282.4%   
Exports (fob) Rs m128,8033,467 3,715.1%   
Imports (cif) Rs m41,4846,654 623.4%   
Fx inflow Rs m128,8033,467 3,715.1%   
Fx outflow Rs m41,4846,654 623.4%   
Net fx Rs m87,319-3,187 -2,739.8%   
CASH FLOW
From Operations Rs m58,87518,525 317.8%  
From Investments Rs m-41,373-142,818 29.0%  
From Financial Activity Rs m-26,861130,487 -20.6%  
Net Cashflow Rs m-9,0736,411 -141.5%  

Share Holding

Indian Promoters % 26.7 40.4 66.0%  
Foreign collaborators % 0.0 20.3 -  
Indian inst/Mut Fund % 47.3 21.1 224.5%  
FIIs % 28.6 6.6 436.9%  
ADR/GDR % 15.3 0.0 -  
Free float % 58.0 39.4 147.4%  
Shareholders   257,794 434,339 59.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Dr. Reddys vs Biocon

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Dr. Reddys vs Biocon Share Price Performance

Period Dr. Reddys Biocon S&P BSE HEALTHCARE
1-Day 1.78% 2.92% 1.18%
1-Month -4.23% -2.53% -0.75%
1-Year 35.93% 30.52% 61.82%
3-Year CAGR 10.85% -13.55% 18.16%
5-Year CAGR 17.77% -2.73% 19.79%

* Compound Annual Growth Rate

Here are more details on the Dr. Reddys share price and the Biocon share price.

Moving on to shareholding structures...

The promoters of Dr. Reddys hold a 26.7% stake in the company. In case of Biocon the stake stands at 60.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Dr. Reddys and the shareholding pattern of Biocon.

Finally, a word on dividends...

In the most recent financial year, Dr. Reddys paid a dividend of Rs 40.0 per share. This amounted to a Dividend Payout ratio of 14.8%.

Biocon paid Rs 1.5, and its dividend payout ratio stood at 28.0%.

You may visit here to review the dividend history of Dr. Reddys, and the dividend history of Biocon.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.